M. Ott

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
  • S. Kafert-Kasting, A. Schneider, M. Attaran, C. Priesner, M. Barthold, A. L. Perrier +3 others
  • 2012
Liver cell transplantation (LCT) is considered a new therapeutic strategy for the treatment of acute liver failure and inborn metabolic defects of the liver. Although minimally invasive, known safety risks of the method include portal vein thrombosis and pulmonary embolism. Since no systematic data on these potential side effects exist, we investigated the(More)
  • 1